ArticleData in brief2026

A longitudinal multi-omic dataset of pediatric cystic fibrosis patients receiving lumacaftor/ivacaftor therapy: clinical, microbiome, inflammatory and metabolomic measurements collected over 24 months.

Rebecca Luise Knoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.